Insiders Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Delayed Nasdaq Other stock markets 19:58:14 15/05/2024 BST			5-day change	1st Jan Change
4.1 ^USD	+3.02%		-3.98%	-25.45%

04-30	Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target	MT
03-27	North American Morning Briefing : Stocks Edge -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marker Therapeutics, Inc. Receives Approval from United States Adopted Name, Council and International Nonproprietary Names Expert Committee for ?Neldaleucel? as Nonproprietary Name for MT-601	01-22	CI
Marker Therapeutics, Inc. Appoints Eliot M. Lurier as Interim Chief Financial Officer	03/07/23	CI
Marker Therapeutics, Inc. Appoints Monic Stuart, M.D., as Chief Medical Officer	08/05/23	CI
Marker Therapeutics, Inc. Announces Management Changes	28/04/23	CI
Marker Therapeutics, Inc. Announces Chief Executive Officer Changes	28/04/23	CI
Marker Therapeutics, Inc. Announces Mythili Koneru, to Resign as Chief Medical Officer, Effective as of April 9, 2023	16/03/23	CI
Marker Therapeutics, Inc. Announces Resignation of Anthony Kim as Chief Financial Officer, Effective September 30, 2022	27/09/22	CI
Marker Therapeutics, Inc. Announces Frederick Wasserman Will Not Stand for Reelection as Director	06/04/22	CI
Marker Therapeutics, Inc. Appoints Katharine Knobil, M.D., to Board of Directors	09/12/21	CI
Insider Trends: Insider Purchase of Marker Therapeutics Stock Prolongs 90-Day Positive Trend	18/03/21	MT
Insider Trends: Insider Purchase of Marker Therapeutics Stock Continues 90-Day Positive Trend	18/03/21	MT
Insider Trends: Marker Therapeutics Insider 90-Day Buying Trend Added to with Purchase	18/03/21	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	18/03/21	MT
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Marker Therapeutics Stock	18/03/21	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	18/03/21	MT
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Marker Therapeutics Stock	18/03/21	MT
Insider Trends: Insider Purchase Continues Marker Therapeutics Positive Trend	18/03/21	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	18/03/21	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	18/03/21	MT
Insider Trends: Insider Buying Continued with Purchase of Marker Therapeutics Stock	18/03/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Marker Therapeutics, Inc.

Equities

MRKR

US57055L2060

Insiders

Filters